Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
about
Deficiency of Nox2 prevents angiotensin II-induced inward remodeling in cerebral arteriolesThe Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of MyofibroblastsNADPH oxidase inhibitors: a decade of discovery from Nox2ds to HTSA Role for the Brain RAS in Alzheimer's and Parkinson's DiseasesAsymmetric dimethylarginine and reactive oxygen species: unwelcome twin visitors to the cardiovascular and kidney disease tablesBiochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular systemAngiotensin II, NADPH oxidase, and redox signaling in the vasculatureReactive oxygen species adversely impacts bone marrow microenvironment in diabetesNADPH oxidases: key modulators in aging and age-related cardiovascular diseases?The vascular endothelium and human diseasesCross talk between mitochondria and NADPH oxidasesOxidases and peroxidases in cardiovascular and lung disease: new concepts in reactive oxygen species signalingThe role of the NADPH oxidase complex, p38 MAPK, and Akt in regulating human monocyte/macrophage survivalBrain-derived neurotrophic factor ameliorates brain stem cardiovascular dysregulation during experimental temporal lobe status epilepticusEffect of exercise on cardiac tissue oxidative and inflammatory mediators in chronic kidney diseaseAdrenomedullin inhibits angiotensin II-induced oxidative stress via Csk-mediated inhibition of Src activityUpregulation of Nox4 in the aging vasculature and its association with smooth muscle cell polyploidyInsulin-like growth factor-I induces reactive oxygen species production and cell migration through Nox4 and Rac1 in vascular smooth muscle cellsDecreased blood pressure in NOX1-deficient miceNOS1 induces NADPH oxidases and impairs contraction kinetics in aged murine ventricular myocytes.Paraoxonase 2 decreases renal reactive oxygen species production, lowers blood pressure, and mediates dopamine D2 receptor-induced inhibition of NADPH oxidaseIsoforms and functions of NAD(P)H oxidase at the macula densa.Oxidative risk for atherothrombotic cardiovascular disease.NADPH oxidases in vascular pathology.Role of NADPH oxidases in liver fibrosis.The quest for selective nox inhibitors and therapeutics: challenges, triumphs and pitfallsRedox control of vascular smooth muscle migration.Nox activator 1: a potential target for modulation of vascular reactive oxygen species in atherosclerotic arteriesCirculating angiotensin II gains access to the hypothalamus and brain stem during hypertension via breakdown of the blood-brain barrier.Mitochondrial KATP channel involvement in angiotensin II-induced autophagy in vascular smooth muscle cells.Oxidative stress and hypertension: Possibility of hypertension therapy with antioxidantsDeterminants of CREB degradation and KChIP2 gene transcription in cardiac memory.C/EBP transcription factors regulate NADPH oxidase in human aortic smooth muscle cells.Inhibition of protein kinase C β(2) prevents tumor necrosis factor-α-induced apoptosis and oxidative stress in endothelial cells: the role of NADPH oxidase subunits.Rac1-dependent intracellular superoxide formation mediates vascular endothelial growth factor-induced placental angiogenesis in vitroLocal regulation of arterial L-type calcium channels by reactive oxygen species.Point mutations in the proline-rich region of p22phox are dominant inhibitors of Nox1- and Nox2-dependent reactive oxygen generation.Vascular oxidative stress: the common link in hypertensive and diabetic vascular disease.Function and design of the Nox1 system in vascular smooth muscle cells.Abnormal fibrillin-1 expression and chronic oxidative stress mediate endothelial mesenchymal transition in a murine model of systemic sclerosis.
P2860
Q21129242-384F946B-CBA8-4D68-A35F-BDEE8557656DQ26766479-B1BD49E3-CAAE-46DC-B1ED-C8DC93C09844Q26821775-DAF76D5A-52CB-4C19-8E8D-E881312F39E1Q26861984-33BAC1DE-7E62-4141-AEEB-866C859FFC43Q26865426-62BE65DF-BBBD-4DE5-B27E-E922EFEEE9EFQ26991619-5208B2B2-DE4A-43D4-99AA-28874792C7AFQ26998758-FCD9A8B3-D27D-4071-9AD2-95718564C3CFQ27002524-5B4E030A-93AA-4E92-9A7B-BB994E39684CQ28072348-210B0E49-1DBB-4BDF-B173-D8D2D9F83397Q28302238-9031B39B-ACFF-4FEE-BDC7-02BDAB005DF2Q28391403-91AD769B-D336-446A-B427-C4F48070230DQ28393242-B420D83E-42BA-45E3-84A7-385785CBAD00Q28396081-75275E0A-3119-424B-8404-3B301A97646BQ28481566-8DAAE028-2897-4409-AAB4-2575BBF5D61DQ28565167-783F0A62-B8B2-4CEF-9BF8-D55EE1C4FD60Q28568524-49515357-6DF9-483B-BC91-C96A6DEBCA12Q28576215-857D35D5-183B-4920-B3EF-1EC88FBB9AF3Q28582797-42693FAB-86EE-43FD-A8EC-9C4395AB5C3EQ28588922-7E22A666-72EF-4D1D-8527-E4D8F089F16CQ30316375-7A800C54-73C5-4F77-BD52-3D941E448AC7Q30417886-3B0D3617-2647-4BFE-8AF1-8A4FC4B296EFQ33407123-35F3E04F-C00D-4A11-B2AE-603ED04956BDQ33554184-466AB50D-F425-4ACE-BAAC-4312FF2092DDQ33632089-F37AA76D-4F77-4E3F-BE64-C963766A486FQ33632736-CB5BC230-BDCB-4069-A3DC-16D78DEB4AB3Q33632757-8C94E6C1-2D26-4360-8361-2974E7423F34Q33690103-AB471AB7-1115-4020-8C8B-3964C8EE2334Q33744942-0CD1F5C0-4D87-4DD9-BF07-DD03A4686FDFQ33842137-CF8A5F77-EB66-4CEB-8CA2-4105EAD8139FQ33877504-A417EC7A-7BEA-482E-818E-94CAF9F88E27Q33971050-1553E76D-D070-49A8-9213-60182B6D4FCCQ33998324-7DCAB171-4E0B-477F-B610-6AF702C1B663Q34011539-835D3B1F-AB92-4216-B413-94001223AAA7Q34133685-7BDCF76D-1D89-4D68-A333-D325F7AC38DBQ34197794-CF9278C7-767A-48D6-B22E-32045CCC99DFQ34257440-4B9FF07D-1BC0-4AF2-927C-EFB743CC21F7Q34430784-3749A3F9-313B-4BEB-A8C2-5A2B7FFDE3DBQ34479731-59608A3C-A351-45ED-AC86-62572BE81741Q34623486-C7B5B8A0-0C66-4D2A-BAAA-7D8012977406Q34718027-235EFCE5-4B56-4D22-92E5-DA4AFB1616C9
P2860
Expression of a functionally active gp91phox-containing neutrophil-type NAD(P)H oxidase in smooth muscle cells from human resistance arteries: regulation by angiotensin II.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
Expression of a functionally active gp91phox-containing neutrophil-type NAD
@nl
Expression of a functionally a ...... regulation by angiotensin II.
@en
type
label
Expression of a functionally active gp91phox-containing neutrophil-type NAD
@nl
Expression of a functionally a ...... regulation by angiotensin II.
@en
prefLabel
Expression of a functionally active gp91phox-containing neutrophil-type NAD
@nl
Expression of a functionally a ...... regulation by angiotensin II.
@en
P2093
P1433
P1476
Expression of a functionally a ...... regulation by angiotensin II.
@en
P2093
Ernesto L Schiffrin
Fatiha Tabet
Guoying Yao
Mark T Quinn
Patrick J Pagano
Rhian M Touyz
P304
P356
10.1161/01.RES.0000020404.01971.2F
P577
2002-06-01T00:00:00Z